You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Details for Patent: 7,553,835


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,553,835
Title:Topical antifungal composition
Abstract:The subject matter relates to a topical, foamable composition including at least one antifungal agent, said composition characterised in that said at least one antifungal agent is able to penetrate the upper layers of skin and is retained in or on an area to be treated for a prolonged period of time, and in that it has a residual non-volatile component content of less than 25%. The subject matter furthermore relates to a method of treating fungal diseases including jock itch, tinea, dandruff and sebborheic dermatitis by applying to the affected area of a patient requiring such treatment the antifungal composition.
Inventor(s): Davey; Greg (Rowville, AU), Abram; Albert Zorko (Rowville, AU)
Assignee: Stiefel Research Australia Pty Ltd (Rowville, AU)
Application Number:09/529,033
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,553,835

Introduction

United States Patent 7,553,835, titled "Topical antifungal composition," is a patent that protects a specific invention related to the treatment of fungal diseases. To delve into the details of this patent, it is crucial to analyze its scope, claims, and the broader patent landscape in which it exists.

Patent Overview

Patent Number and Title

  • The patent number is 7,553,835, and the title is "Topical antifungal composition."

Invention Description

  • This patent describes a method and composition for treating fungal diseases such as jock itch, tinea, dandruff, and seborrheic dermatitis through the application of a topical antifungal composition[5].

Patent Scope

Definition of Patent Scope

  • Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims of the patent, which define the boundaries of the invention[3].

Claims Analysis

  • The claims of a patent are the most critical part of the patent document as they define what is protected by the patent. For US Patent 7,553,835, the claims would typically include:
    • Independent Claims: These claims stand alone and define the invention without reference to other claims.
    • Dependent Claims: These claims refer back to and further limit the independent claims.
    • Claim Language: The language used in the claims is crucial. Narrower claims with specific language are generally easier to enforce and less likely to be challenged than broader claims[3].

Claim Metrics

  • Research has shown that narrower claims, measured by independent claim length and independent claim count, are associated with a higher probability of grant and a shorter examination process. This suggests that the claims in US Patent 7,553,835 would likely be scrutinized for their breadth and clarity during the examination process[3].

Patentability Requirements

  • To be patentable, an invention must meet several requirements:
    • Utility: The invention must be operable and provide some tangible benefit.
    • Novelty: The invention must not be fully anticipated by prior art.
    • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[4].

Examination Process

  • The USPTO examiner evaluates the patent application based on these requirements. The examination process can narrow the scope of patent claims, particularly if the claims are initially broad. This process ensures that the granted patent is valid and does not overly broaden the scope of protection[3].

Continuation Procedures

  • During the examination process, applicants may use continuation procedures such as Requests for Continued Examination (RCEs) to address non-final rejections. These procedures can affect the final scope and claims of the patent. For example, 19.5% of all applicants and 38.7% of applicants receiving a non-final rejection file at least one RCE[1].

Technology Field

  • US Patent 7,553,835 falls under the "Drugs and Medical Instruments" field, one of the broad technology fields categorized by the USPTO. This field has seen a decrease in the allowance rate over time, indicating a more stringent examination process[1].

Patent Landscape

  • The patent landscape for antifungal compositions is competitive, with numerous patents and ongoing research in this area. The validity and enforceability of US Patent 7,553,835 would depend on its uniqueness and the specificity of its claims relative to existing prior art.

Legal Rights and Duration

  • A granted patent confers the right to exclude others from making, using, offering for sale, or selling the covered invention in the United States for a period of 20 years from the date the patent application was filed. This period is crucial for the patent holder to recoup investment and benefit from the invention[4].

Industry Impact

  • Patents like US 7,553,835 play a significant role in driving innovation in the pharmaceutical and medical fields. They provide incentives for research and development by protecting intellectual property and allowing companies to recover their investments.

Key Statistics

  • Allowance Rate: Only 55.8% of patent applications filed at the USPTO are eventually granted without using continuation procedures[1].
  • Examination Duration: The examination process can take four to five years after the filing date, with the scope of claims often narrowing during this period[1].

Expert Insights

  • According to industry experts, the quality of patents, including their scope and claims, is a critical factor in innovation. Narrower, clearer claims are generally preferred as they reduce litigation and licensing costs, thereby promoting innovation[3].

Highlight

"The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, and that the changes are more significant when the duration of examination is longer."[3]

Key Takeaways

  • Patent Scope and Claims: The scope and claims of a patent define its boundaries and are crucial for its validity and enforceability.
  • Patentability Requirements: Inventions must be useful, novel, and nonobvious to be patentable.
  • Examination Process: The USPTO examination process can narrow the scope of claims, especially in competitive fields like "Drugs and Medical Instruments."
  • Continuation Procedures: RCEs and other continuation procedures can impact the final scope and claims of a patent.
  • Legal Rights and Duration: A granted patent provides exclusive rights for 20 years from the filing date.

FAQs

Q: What are the key requirements for an invention to be patentable?

  • An invention must be useful, novel, and nonobvious to be patentable.

Q: How does the USPTO examination process affect patent claims?

  • The examination process can narrow the scope of patent claims, particularly if the claims are initially broad.

Q: What is the significance of continuation procedures in patent applications?

  • Continuation procedures, such as RCEs, allow applicants to address non-final rejections and can impact the final scope and claims of the patent.

Q: How long does a patent provide exclusive rights?

  • A granted patent provides exclusive rights for 20 years from the date the patent application was filed.

Q: Why are narrower claims generally preferred in patent applications?

  • Narrower claims are associated with a higher probability of grant, a shorter examination process, and reduced litigation and licensing costs.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. U.S. Patent and Trademark Office (USPTO). (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. Patent Claims and Patent Scope. (2016). SSRN.
  4. Patents and Innovation Policy. (2022). CRS Reports.
  5. Topical antifungal composition - Patent US-7553835-B1. (n.d.). PubChem.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,553,835

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 7,553,835

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPO9838Oct 17, 1997
AustraliaPP1217Jan 06, 1998
PCT Information
PCT FiledOctober 19, 1998PCT Application Number:PCT/AU98/00867
PCT Publication Date:April 29, 1999PCT Publication Number: WO99/20250

International Family Members for US Patent 7,553,835

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 732456 ⤷  Try for Free
Australia 9728898 ⤷  Try for Free
Austria 346588 ⤷  Try for Free
Canada 2306560 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.